ApoB: The Cholesterol Number Every Executive Should Know

Executives are fluent in metrics. You review pipeline, churn, runway, and margins weekly, and you would never run a company on a number that only approximates the truth. Yet when it comes to the single metric that best predicts how long you will be around to run the company, most high performers are still relying on a sixty-year-old approximation — the standard cholesterol panel — and calling it prevention. Here is the uncomfortable stat I share with every client over forty: cardiovascular disease remains the leading cause of death for executives, and it typically presents with no warning symptoms in busy, fit-looking people. The good news is that the biology is unusually measurable and unusually modifiable, provided you measure the right thing. That thing is ApoB. In my practice, I have seen countless panels where LDL cholesterol looked perfectly acceptable while the ApoB number told a very different story. This article covers what ApoB is, why it beats LDL cholesterol as a predictor, the one genetic test every executive should get exactly once, what drives the number up in high performers specifically, and the protocol I use to bring it down.

What ApoB actually is — and why particle count beats cholesterol content

Every atherogenic lipoprotein particle in your blood — every LDL particle, every VLDL, every remnant — carries exactly one molecule of apolipoprotein B on its surface. ApoB is the structural ticket that allows the particle to dock on your artery wall. That gives you a remarkably clean piece of math: your ApoB level is a direct count of how many artery-damaging particles are circulating, not an estimate of how much cholesterol they happen to be carrying. This distinction matters because the standard LDL cholesterol number (LDL-C) measures cargo concentration, while ApoB measures the number of trucks. Two people can have identical LDL-C values while one carries half the particle count — and it is the particle count that drives plaque. Particles get into the artery wall in proportion to how many there are and how long they linger, which is why atherosclerosis tracks ApoB across a lifetime. This is the framing I apply to all testing in Executive Bloodwork and Biomarkers: the number that most directly reflects the mechanism is the number worth tracking.

Why your standard lipid panel can mislead you

The discordance between LDL-C and ApoB is not a rare curiosity — it is common enough that I see it weekly in high performers. The normal-LDL, high-ApoB pattern. When insulin resistance and visceral fat shift your particle distribution toward small, dense, cholesterol-depleted particles, you can have a modest total cholesterol cargo spread across a large number of particles. The panel reports a reassuring LDL-C; the ApoB reports the truth. This is the exact metabolic signature I describe in Visceral Fat and Executive Longevity and Metabolic Health — and it is the pattern that catches fit-looking executives by surprise. The high-LDL, normal-ApoB pattern. Less common but worth knowing: some people carry large, cholesterol-rich particles, where LDL-C looks alarming but particle count is unremarkable. The calculation problem. LDL-C is often calculated, not directly measured, and the equations lose accuracy when triglycerides run high — which they do in executives drinking regularly and eating late. I have had clients with calculated LDL-C of 105 and an ApoB in the top decile of risk. Nobody gets a heart attack from a calculated number that flatters them; they get it from particles.

The once-in-a-lifetime test: lipoprotein(a)

There is one more particle worth knowing about, and you only need to measure it once. Lipoprotein(a), usually written Lp(a), is an LDL-like particle with an additional protein wrapped around it. Its level is almost entirely genetic — diet and exercise barely move it — and roughly one in five people carry elevated levels, most without knowing it. Elevated Lp(a) independently accelerates atherosclerosis and aortic valve disease, which means it can turn a merely average ApoB into a serious lifetime risk. Because it is set at birth and stable for life, one measurement settles the question forever: either you know, or you spend decades unaware. I fold the Lp(a) request into the baseline workup for every client, alongside the markers in Blood Pressure and Cardiovascular Health for Executives. If yours comes back elevated, the strategy shifts from lowering ApoB aggressively to lowering it maximally — the margin you control becomes your margin of safety.

What drives ApoB up in high performers specifically

Executives are not more prone to high ApoB because of bad luck; the lifestyle compiles it. Visceral fat. Belly fat is metabolically active tissue that floods the liver with fatty acids, and the liver responds by shipping out more VLDL particles — the raw material that becomes LDL. Every inch of visceral fat raises particle output; this is the mechanism that ties your waistline directly to your arteries. Refined carbohydrates and late eating. Excess carbohydrate, particularly fructose from sugary drinks and late-night meals, drives hepatic fat and triglyceride production. The eating-pattern fixes in Time-Restricted Eating for Executives and Fasting and Metabolic Reset lower particle output at the source. Alcohol. Regular drinking raises triglycerides and, with them, particle count — one more entry on the cost ledger in Alcohol, Sleep, and Recovery: The Honest Math. Poor sleep and chronic stress. Both elevate the insulin resistance and inflammatory tone that shift particles toward the small dense pattern, connecting this number to the sleep architecture work in Sleep Optimization for Executives and the stress physiology in Cortisol and Performance. Under-muscled bodies. Skeletal muscle is your largest site of glucose and fat disposal; the strength work in Strength Training After 40 is not just about muscle — it is about giving particles somewhere to go.

How to lower it: the protocol that actually moves the number

ApoB is highly modifiable, and the levers compound. One: attack visceral fat first. Nothing lowers particle production more reliably than losing the belly fat driving it — which is why the waistline and the bloodwork improve together in the visceral fat work. Two: restructure dietary fat. Replacing saturated fat (fatty red meat, butter, cream) with unsaturated sources (olive oil, nuts, fatty fish) reliably lowers ApoB; the food-first framework lives in Nutrition Fundamentals That Actually Work, and the omega-3 piece specifically pulls triglycerides down — see Omega-3s for Executives. Three: push fiber and soluble fiber hard. Oats, beans, psyllium — soluble fiber binds bile acids and forces your liver to pull cholesterol out of circulation. Four: train both ends. Aerobic base work lowers ApoB modestly and improves particle quality, and the adaptation is measurable in the capacity numbers from Zone 2 Training for Executives and VO2 Max: The Longevity Metric Every Executive Should Train. Five: cut the alcohol and fix the sleep. Both raise the number directly and indirectly, and both respond quickly to intervention. Six: when lifestyle is not enough, use the pharmacology. This is the part I insist clients discuss with their physician rather than read about: statins, ezetimibe, and PCSK9 inhibitors each lower ApoB by different mechanisms, and they are dramatically safer and more effective than their reputation suggests. An ApoB that stays elevated despite a disciplined lifestyle is not a discipline problem — it is a numbers problem with excellent medical solutions. My role is getting the lifestyle levers truly dialed first, then making the conversation with the prescriber short.

The executive's cardiovascular numbers checklist

Here is the sequence I run with clients, in order. Baseline: ApoB, full lipid panel with direct LDL, triglycerides, high-sensitivity CRP, blood pressure, and Lp(a) once in your life — the full dashboard logic is in Executive Bloodwork and Biomarkers. Targets: for a forty-plus executive optimizing for longevity, I aim for ApoB under roughly 80 mg/dL as a floor, and for clients with elevated Lp(a), existing plaque, or a family history of early heart disease, I aim lower — under 60, sometimes under 50, which is where the evidence for maximal prevention lives. Re-test: three to six months after any meaningful intervention, because ApoB responds to behavior faster than almost any biomarker in the panel, and the same before-and-after discipline applies that I describe in Recovery Metrics: HRV, RHR, and Sleep Score. Context: ApoB never gets read in isolation — alongside blood pressure, glucose stability from Blood Sugar and Executive Focus, inflammatory tone from Inflammation and Modern Performance, and the systemic picture in Longevity Strategies for High Performers. I wrote a companion piece on the same theme over at jasonleerannfeldt.me for readers who want the shorter version.

The bottom line

The standard cholesterol panel was a triumph of 1960s medicine and it is now the floor, not the ceiling, of cardiovascular risk assessment. ApoB counts the particles that actually drive plaque, Lp(a) reveals the genetic hand you were dealt, and both are one blood draw away. The executives I work with measure everything in their business; measuring the number that predicts whether they will be around to enjoy the business is the highest-leverage metric review of the year. If you want your bloodwork, nutrition, training, sleep, and stress load sequenced into one system built around your actual calendar, that is the work inside Crush 90 and Thrive 90. Start with a short conversation on the contact page, or read more about the approach on the about page.